Biocon Ltd
NSE:BIOCON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kiler Gayrimenkul Yatirim Ortakligi AS
IST:KLGYO.E
|
TR |
|
T
|
Turbine Aviation Inc
OTC:TURA
|
US |
During the last 3 months Biocon Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 3% over this period (open performance analysis).
The last transaction was made on
Jun 8, 2019
by
Biocon India Limited Employee Welfare Trust
, who
sold
24.7m INR
worth of 
BIOCON shares.
During the last 3 months Biocon Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 3% over this period (open performance analysis).
The last transaction was made on
Jun 8, 2019
by
Biocon India Limited Employee Welfare Trust
, who
sold
24.7m INR
worth of BIOCON shares.
Biocon Ltd
Glance View
In the bustling world of biotechnology, Biocon Ltd. stands as a beacon of innovation, rooted in its Indian origins yet extending its influence globally. Founded in 1978 by Kiran Mazumdar-Shaw, a visionary with a degree in fermentation science, Biocon began its journey as a maker of enzymes before transforming into a formidable force in biopharmaceuticals. This transformation was driven by the company's emphasis on research and development, leading to groundbreaking advancements in biosimilars, generics, and novel biotherapeutics. These products cater to critical areas such as oncology, diabetes, and autoimmune diseases. The company's success hinges on its ability to blend scientific rigor with entrepreneurial flair, enabling it to deliver high-quality, cost-effective solutions in a market traditionally dominated by Western giants. Biocon's revenue model is intricately woven from various strands of its expansive portfolio. A significant chunk emerges from its biologics division, where it manufactures biosimilars that serve as cost-friendly alternatives to expensive biologic drugs. Simultaneously, the company capitalizes on its expertise in small molecule APIs and branded formulations, which are integral to its generics business. Furthermore, collaborations and partnerships with global pharmaceutical companies amplify its reach, facilitating market access and regulatory navigation. Through these strategic undertakings, Biocon not only bolsters its financial performance but also reinforces its commitment to enhancing healthcare affordability and accessibility across the globe.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
